SEC Form 4 · accession 0001179110-16-031100
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Brannon Johnston
Officer — Chief Financial Officer
Period of report
Nov 2, 2016
Accepted (ET)
Nov 3, 2016 · 11:12 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 2, 2016 | P | 10,000 | $1.6981 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.